|
|
 |
|
NVS: Novartis Ag - Stock News |
Enter Ticker:
|
|
| Nov 19, 2009 |
House Energy and Commerce Subcommittee on Health, and Oversight and Investigations Hearing |
| Nov 19, 2009 |
House Energy and Commerce Subcommittee on Health, and Oversight and Investigations Hearing |
| Nov 19, 2009 |
Beacon Equity Issues Technical Trading Overview for Questcor Pharmaceuticals Inc. |
| Nov 19, 2009 |
NORVATIS EARMARKS US$1.3 BLN TO MAKE CHINA 3RD DRUG R&D BASE |
| Nov 18, 2009 |
Malaysia: Novartis Teams Up With Malaysia In Bioactive Compounds Research |
| Nov 18, 2009 |
Malaysia : Novartis, SBC sign pact on biotech venture |
| Nov 18, 2009 |
Dispensary of Hope Partners with Leading Pharma Companies to Expand Prescription Medications Access to Tennesseans in Need |
| Nov 18, 2009 |
ABLYNX ACHIEVES THIRD MILESTONE IN DRUG DISCOVERY AND DEVELOPMENTCOLLABORATION |
| Nov 18, 2009 |
Sales of Therapies to Treat Diabetic Retinopathy, Diabetic Neuropathy and Diabetic Nephropathy Will Increase by More Than 70 Percent Through 2018 |
| Nov 18, 2009 |
Anti-Smoking Vaccine from Glaxo |
| Nov 18, 2009 |
NOVARTIS TEAMS UP WITH MALAYSIA IN BIOACTIVE COMPOUNDS RESEARCH |
| Nov 17, 2009 |
Novartis Says Half Dose of H1N1 Vaccine Sufficient |
| Nov 16, 2009 |
Serbia : Agreement on procurement of vaccines from Novartis signed |
| Nov 16, 2009 |
Zacks Analyst Blog Highlights: GlaxoSmithKline plc, Sanofi-Aventis, Novartis, Baxter International and AstraZeneca |
| Nov 14, 2009 |
Switzerland : Further Novartis H1N1 vaccine cleared in Switzerland |
| |
| ZACKS COMMENTARY FOR NVS |
| Nov 17, 2009 | Zacks Blog: Anti-Smoking Vaccine from Glaxo | | Nov 16, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: GlaxoSmithKline plc, Sanofi-Aventis, Novartis, Baxter International and AstraZeneca | | Nov 13, 2009 | Zacks Blog: Glaxo H1N1 Vaccine Approved | | Nov 13, 2009 | Zacks Blog: Gilead Awaits Committee Outcome | | Nov 12, 2009 | Zacks Blog: Wider Loss for Alnylam | | Nov 10, 2009 | Zacks Blog: Zacks Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences, Biogen Idec and Acorda Therapeutics | | Nov 10, 2009 | Zacks Analyst Interviews: Big Pharma & Biotech | | Nov 10, 2009 | Industry Outlook: Big Pharma & Biotech | | Nov 09, 2009 | Zacks Blog: Big Pharma and Biotech | | Nov 09, 2009 | Zacks Equity Research: Report for NVS | | Nov 05, 2009 | Zacks Blog: Lower Q3 Loss for Human Genome | | Oct 19, 2009 | Zacks Blog: FDA Delays Novartis Treatment |
|
|
Sponsored Links 
-0.16